FDAnews Announces — OTC Labeling and Advertising: Claims, Compliance and Avoiding Enforcement Action Webinar, Sept. 14, 2016

Share Article

What are the most significant new developments that marketers of OTC drugs face? Stacy Ehrlich and Will Woodlee, Partners at Kleinfeld, Kaplan & Becker, LLC, will discuss what OTC drug products require premarket approval, labeling and promotion rules, and common but avoidable mistakes in marketing OTC drug products.

OTC Labeling and Advertising:
Claims, Compliance and Avoiding Enforcement Action
**An FDAnews Webinar**
Sept. 14, 2016 — 1:30 p.m. – 3:00 p.m. ET
http://info.fdanews.com/otc-labeling-and-advertising-vocus        

What are the chances that the FDA will introduce user fees for OTC monograph drugs in the next six months?

What lines has the FDA drawn between drugs and cosmetics that directly impact the approval and labeling of OTC products?

Why is the FDA looking so intensely at homeopathic drug products?

These are all things manufacturers of OTCs need to know.

Stacey Erhlich and Will Woodlee — Partners at Kleinfed, Kaplan & Becker, LLC — will discuss what OTC drug products require premarket approval, labeling and promotion rules, and common but avoidable mistakes in marketing OTC drug products.

After attending this webinar attendees will be able to:

  •     Comply with updated OTC mongographs on antiseptics, sunscreen, and cough and cold products
  •     Realize why OTC manufacturers must pay as much attention to FTC enforcement and marketing and promotion rules as they do to FDA regulation.
  •     Learn cost-saving risk mitigation strategies in labeling and marketing to improve bottom line performance.

Register today and avoid the common mistakes in marketing OTC drug products.

Meet the Presenter:
Stacy Ehrlich, Partner, Kleinfeld, Kaplan & Becker, LLP
Stacey Ehrlich’s law practice focuses on counseling and advocating on behalf of pharmaceutical, food, dietary supplement, tobacco, cosmetic, and medical device companies on a variety of matters involving FDA, USDA, and FTC, as well as state agencies. Ms. Ehrlich has substantial expertise with regard to product approvals, labeling and promotion, OTC switches, food safety and ingredients, and corporate due diligence matters.

Will Woodlee, Partner, Kleinfeld, Kaplan, and Becker, LLP

Will Woodlee’s practice focuses primarily on counseling and advocating on behalf of food, dietary supplement, cosmetic, pharmaceutical, medical device, tobacco, and consumer product companies on regulatory and advertising law matters.

Who Will Benefit:

  •     Regulatory Affairs
  •     Quality Assurance
  •     Marketing Professionals
  •     Attorneys
  •     Consultants

Webinar Details:
OTC Labeling and Advertising:
Claims, Compliance and Avoiding Enforcement Action
Sept. 14, 2016 — 1:30 p.m. – 3:00 p.m. ET
http://info.fdanews.com/otc-labeling-and-advertising-vocus

Tuition:
$287 per site

Easy Ways to Register:
Online:     http://info.fdanews.com/otc-labeling-and-advertising-vocus                            
By phone: 888-838-5578 or 703-538-7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michelle Butler
FDANEWS
+1 (703) 538-7665
Email >
FDAnews
Like >
Visit website